If you need more lookups,
subscriptions start at $34 USD/month.
Robert Huizinga Work
2025 -now Interim Chief Executive Officer @
2024 -2025 Executive Chairman @
2018 -2024 Member of The Scientific Advisory Board @
2022 -now Founder and CEO @
2023 -now Advisor @
2023 -now Adjunct Professor @
2019 -now Adjunct Professor, Leder School of Business @
2024 -2025 Past Chair, Board of Governors @
2021 -2024 Chairperson, Board of Governors @
2020 -2021 Board of Governors, Vice-Chair @
2010 -2024 Equip Partner @
2020 -2022 Executive Vice President, Research @
2017 -2020 Executive Vice President Corporate Development @
2013 -2017 Vice President, Clinical Affairs @
2013 -2019 Board Member @ biovialife
2013 -2016 Board Member @
2011 -2013 Vice President, Clinical Affairs @
2006 -2011 Sr. Director, Clinical Affairs @
2002 -2006 Director, Clinical Affairs @
1991 -2002 Research Epidemiologist and Nephrology Nurse Clinician @
1994 -1998 Founder and Moderator of RenalPro @
1988 -1991 Registered Nurse, Nephrology @
Robert Huizinga Education
University of Alberta
Registered Nurse - RN
Regent University
Doctor of Philosophy - PhD (Organizational Leadership)
University of Alberta
Master of Science - MS (Clinical Epidemiology)
Robert Huizinga Skills
Strategic Leadership
Leadership Development
Cross-functional Team Leadership
Public Speaking
Clinical Development
Biotechnology
Drug Development
Clinical Research
Pharmaceutical Industry
Leadership
CRO
Strategy
Protocol
Lifesciences
Life Sciences
Transplant
Diabetes
Clinical Operations
Clinical Trials
ICH-GCP
Healthcare
GCP
Infectious Diseases
CTMS
Regulatory Affairs
Statistics
Commercialization
Biopharmaceuticals
FDA
Regulatory Submissions
Nephrology
Guest Lecturing
Data Management
Medical Devices
Neurology
Epidemiology
Medical Writing
Corporate Governance
Corporate Development
Clinical Monitoring
Product Lifecycle Management
EDC
Sop
Cross-cultural Teams
Transplantation
Good Clinical Practice (GCP)
CRO Management
Cross Cultural Teams
Cross Functional Team Leadership
Oracle Clinical
Ich Gcp
Dermatology
Clinical Trial Management
Product Life Cycle Management
Good Clinical Practice Gcp
Cancer
Good Clinical Practice
Robert Huizinga Summary
Robert Huizinga, is currently a Interim Chief Executive Officer at Kane Biotech Inc.. Robert Huizinga brings experience from previous roles at Kane Biotech Inc., Reformation Consulting Services Inc. and Avivo Biomedical Inc.. Robert Huizinga holds a Registered Nurse - RN @ University of Alberta. With a robust skill set that includes Strategic Leadership, Leadership Development, Cross-functional Team Leadership, Public Speaking, Clinical Development and more. Robert Huizinga has 5 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Robert Huizinga?
Find contact details for 700 million professionals.